United States · FDA National Drug Code directory
DYANAVEL XR
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 24478-106_32c90701-fe4a-4d5a-b3bb-e9ccf0416ece
- Product NDC
- 24478-106
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- amphetamine
- Labeler
- NextWave Pharmaceuticals, Inc
- Marketing category
- NDA
- Marketing start / end (source format)
- 20211104
- Source listing expiry
- 20271231
Source-listed ingredients
- AMPHETAMINE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (24478-106-01) · 24478-106-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →